The Bottom Line Catch Up | Ep. 4 | Peptides, Nexus Issues & Trade Show Takeaways

Send us Fan MailWelcome to another episode of the Bottom Line Catch Up! This week our team is talking all about Peptides, Nexus Issues, and Trade Show Trends.  In this episode, we break down:- Where things stand with the FDA Bulks List and state-by-state variation- Nexus issues for pharmacies shipping and operating across state lines- MFP (Maximum Fair Price) accounting- Takeaways from Cencora, RBC, and other summer shows- Plus: fantasy football team names, upcoming conferences (APC, NCPA), and a few tangents you'd expect from the crewStay connected with us: FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterBonnie Bond – CPA LinkedInBonnie Bond – CPA Twitter More resources on this topic: Podcast - The Bottom Line Catch Up | Ep. 3 | R&D Tax Credit, Trump Accounts, Taylor Swift's WeddingPodcast – Peptides, Policy, and PBMs: 2026 Quarter 3 Pharmacy UpdatePodcast – Infusion Pharmacy Ownership in 2026: The Legal Side of Infusion Pharmacy